This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of compounds targeting neurological and psychiatric disorders. Its structure, featuring a benzylpiperidine moiety, makes it particularly valuable in the design of molecules that interact with central nervous system receptors, such as dopamine or serotonin receptors. Researchers explore its potential in developing treatments for conditions like schizophrenia, depression, and anxiety disorders. Additionally, it may be investigated for its role in modulating enzyme activity or protein interactions, contributing to the development of novel therapeutic agents.